-
Company Insights
Innovation and Patenting activity of Arcs Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Arcs Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Thematic Analysis
NewWeb3 – Thematic Intelligence
Web3 Thematic Report Overview Web3 is an ideology that refers to the next model of the internet built on blockchain. It promises a mix of peer-to-peer (P2P) communication channels and decentralized governance. This will lead the internet’s transition from an information-centric model to a user-centric model. Furthermore, Web3 aims to give users the ability to create, own, and monetize their content and manage the use of their data. However, it is still an emerging model and has a long way...
-
Sector Analysis
Dental Light Cure Equipment Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Dental Light Cure Equipment Market Report Overview The dental light cure equipment market size was valued at $281.7 million in 2023 and will grow at a CAGR of more than 3% during 2023-2033. Factors such as the growing elderly population will support the market growth. Dental curing lights are used to cure a wide range of dental materials that are light-curable. The light that is used ranges within the visible blue light spectrum. The wavelength of the light emitted varies...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-172154 in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-172154 in Epithelial Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SL-172154 in Epithelial Ovarian Cancer Drug Details: SL-172154 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-172154 in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-172154 in Refractory Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SL-172154 in Refractory Acute Myeloid Leukemia Drug Details: SL-172154 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-172154 in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-172154 in Metastatic Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SL-172154 in Metastatic Ovarian Cancer Drug Details: SL-172154 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-172154 in Myelodysplastic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-172154 in Myelodysplastic Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SL-172154 in Myelodysplastic Syndrome Drug Details: SL-172154 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-172154 in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-172154 in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SL-172154 in Relapsed Acute Myeloid Leukemia Drug Details: SL-172154 is...
-
Product Insights
External Remote Patient Monitoring Devices Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies
External Remote Patient Monitoring Devices Pipeline Market Report Overview An External Remote Patient Monitoring Device retrieves the data from the external measurement device such as glucose meters. The device then transmits the data through a wireless system to a monitoring station or a physician’s office for further analysis and interpretation. The External Remote Patient Monitoring Devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report...